Emergent Biosolutions's total assets for Q3 2025 were $1.46B, a decrease of ― from the previous quarter. EBS total liabilities were $878.50M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.